IP Library Granted Patent US 9,018,406
Granted Patent B2
US 9,018,406 · App. 13/781,563 · Granted Apr 28, 2015

Dicarboxylate-capped estolide compounds and methods of making and using the same

Inventors: Jeremy Forest (Irvine, CA); Jakob Bredsguard (Lake Forest, CA)
Assignee: Biosynthetic Technologies, LLC
C10M105/42C10M105/40C10M2207/301C10N2230/02C10N2230/10C10N2230/12C10N2230/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,018,406
App. No.
13/781,563
Granted
Apr 28, 2015
Kind
B2
Abstract

Described herein are dicarboxylate-capped estolide compound and methods of making the same. Exemplary dicarboxylate-capped estolide compounds include those of the formula x is, independently for each occurrence, an integer selected from 0 to 20; y is, independently for each occurrence, an integer selected from 0 to 20; W is, independently for each occurrence, selected from —CH 2 — and —CH═CH—; z is an integer selected from 1 to 40; n is an integer equal to or greater than 0; R 5 is selected from hydrogen, optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched, and an estolide residue; and R 2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched, wherein each fatty acid chain residue of said at least one compound is independently optionally substituted.

Claims (40)

1. At least one compound of Formula I:

wherein

x is, independently for each occurrence, an integer selected from 2 to 8;

y is, independently for each occurrence, an integer selected from 0 to 20;

z is an integer selected from 4 to 18;

n is an integer selected from 0 to 6;

W is, independently for each occurrence, selected from —CH 2 — and —CH═CH—;

R 5 is selected from hydrogen, unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched, and an estolide residue; and

R 2 is selected from hydrogen and unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched,

wherein each fatty acid chain residue of said at least one compound is unsubstituted.

2. The at least one compound according to claim 1 , wherein x+y is, independently for each occurrence, an integer selected from 13 to 15.

3. The at least one compound according to claim 1 , wherein z is an integer selected from 6 to 16.

4. The at least one compound according to claim 1 , wherein z is 10.

5. The at least one compound according to claim 1 , wherein n is 0.

6. The at least one compound according to claim 1 , wherein R 5 and R 2 are hydrogen.

7. The at least one compound according to claim 1 , wherein R 2 is a branched or unbranched C 1 to C 20 alkyl that is saturated or unsaturated.

8. The at least one compound according to claim 1 , wherein R 5 is a branched or unbranched C 1 to C 20 alkyl that is saturated or unsaturated.

9. The at least one compound according to claim 1 , wherein R 5 is an estolide residue selected from the structure of Formula III:

wherein

x′, independently for each occurrence, is an integer selected from 0 to 20;

y′, independently for each occurrence, is an integer selected from 0 to 20;

n′ is an integer selected from 0 to 6; and

R 6 is selected from hydrogen and unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched.

10. The at least one compound according to claim 9 , wherein

x′ is, independently for each occurrence, an integer selected from 7 and 8; and

y′ is, independently for each occurrence, an integer selected from 7 and 8.

11. The at least one compound according to claim 9 , wherein n′ is 0.

12. The at least one compound according to claim 1 , wherein

n is 0;

x is, independently for each occurrence, an integer selected from 7 and 8;

y is, independently for each occurrence, an integer selected from 7 and 8; and

R 5 and R 2 are independently selected from branched C 4 to C 20 alkyl.

13. The at least one compound according to any claim 3 , wherein z is 16.

14. The at least one compound according to claim 1 , wherein W is —CH 2 —.

15. The at least one compound according to claim 1 , wherein y is 0 for each occurrence.

16. The at least one compound according to claim 15 , wherein x is, independently for each occurrence, and integer selected from 7 and 8.

17. The at least one compound according to claim 16 , R 5 and R 2 are independently selected from unsubstituted C 1 to C 20 alkyl that is saturated and branched or unbranched.

18. The at least one compound according to claim 16 , wherein R 5 and R 2 are independently selected from branched C 4 to C 20 alkyl.

19. The at least one compound according to claim 18 , wherein R 5 and R 2 are 2-ethylhexyl.

20. The at least one compound according to claim 9 , wherein z is an integer selected from 6 to 16.

Assignments (6)
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK OIL ADDITIVES USA, INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045684/0293 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: BP TECHNOLOGY VENTURES INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045688/0600 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK CORPORATION
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045860/0547 →
SECURITY INTEREST Recorded Jan 30, 2018
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: BP TECHNOLOGY VENTURES INC.
Reel/Frame 045196/0587 →
SECURITY INTEREST Recorded Mar 18, 2016
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK OIL ADDITIVES USA, INC.
Reel/Frame 038146/0859 →
SECURITY INTEREST Recorded Nov 30, 2015
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK CORPORATION
Reel/Frame 037162/0364 →
Continuity (2)
Provisional Application 61616041 · Mar 27, 2012
Related Publication 20130261325A1 · Oct 3, 2013